One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
National Health Investors logo
National Health Investors NHI
$ 66.01 -2.61%
report update icon

Quarterly report 2026-Q3
added 11-09-2026

National Health Investors Financial Statements 2025-2007 | NHI

Annual Financial Statements National Health Investors

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Market Cap

3.5 B 3.13 B 2.29 B 2.59 B 2.59 B 2.86 B 3.71 B 3.43 B 2.84 B 2.87 B 2.28 B 2.5 B 1.78 B 945 M 1.34 B 1.11 B 735 M 859 M -

Shares

46.9 M 43.8 M 43.4 M 44.8 M 45.7 M 44.7 M 43.4 M 41.9 M 40.9 M 39 M 37.6 M 33.4 M 28.4 M 27.8 M 27.7 M 27.7 M 27.6 M 27.7 M -

Historical Prices

74.6 71.4 52.9 57.8 56.6 64.1 70.4 61.9 58.5 54.7 42.7 46.6 35.5 34 24.9 40 26.6 31 35.5

Net Income

142 M 138 M 136 M 66.4 M 112 M 185 M 160 M 154 M 159 M 152 M 149 M 102 M 106 M 90.7 M 81.1 M 69.4 M 64.2 M 57.5 M -

Revenue

376 M 335 M 320 M 278 M 299 M 333 M 318 M 295 M 279 M 248 M 229 M 178 M 118 M 93.3 M 82.7 M 82.6 M 62.8 M 56.9 M -

Cost of Revenue

27.5 M 17.2 M 16.2 M 11.2 M - - - - - - - - - - - - - - -

Gross Profit

348 M 318 M 304 M 267 M - - 311 M 293 M 278 M 247 M 228 M 177 M 117 M - 82.7 M - - - -

Operating Income

- - - - - - - - - - 150 M 103 M 79.5 M 72.8 M 61.9 M 61.8 M 48.7 M 44.6 M -

Interest Expense

57.4 M 59.9 M 58.2 M 44.9 M 50.8 M 52.9 M 56.3 M 49.1 M 46.3 M 43.1 M 37.6 M 26.4 M 9.23 M 3.49 M 3.85 M 1.55 M 269 K - -

EBITDA

80.9 M 71.4 M 70 M 70.9 M 80.8 M 83.2 M 297 M 281 M 265 M 237 M 217 M 168 M 107 M 72.8 M 73.8 M 61.8 M 48.7 M 44.6 M -

Operating Expenses

239 M 212 M 201 M 242 M 216 M 162 M 90.7 M 84.2 M 79.9 M 69.8 M 64.1 M 47.4 M 30.1 M 25.4 M 20.8 M 21.1 M 14.1 M 12.3 M -

General and Administrative Expenses

26.9 M 20.7 M 19.3 M 22.8 M 18.4 M 13.3 M 13.9 M 12.9 M 12.7 M 10.2 M 11 M 9.32 M 10 M 7.8 M 8.03 M 7.79 M 5.26 M 3.58 M -

All numbers in USD currency

Quarterly Income Statement National Health Investors

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q4 2010-Q3 2010-Q2

Shares

49 M 48.4 M 48.3 M 259 K 47.4 M 46.7 M 45.7 M 424 K 43.5 M 43.4 M 43.4 M 43.4 M 43.4 M 43.4 M 43.4 M 43.4 M 44.3 M 45.7 M 45.9 M 45.9 M 45.9 M 45.9 M 45.3 M 44.9 M 44.7 M 44.7 M 44.6 M 44.1 M 43.5 M 43.2 M 42.8 M 42.4 M 42.2 M 41.7 M 41.5 M 41.5 M 41.1 M 41 M 40 M 39.8 M 39.3 M 38.5 M 38.4 M 37.7 M 37.6 M 37.6 M 37.6 M 34.3 M 33.1 M 33.1 M 33.1 M 29.8 M 27.9 M 27.9 M 27.9 M 27.8 M 27.8 M 27.8 M 27.8 M 27.7 M 27.7 M 27.7 M 27.7 M 27.7 M 27.7 M 27.7 M

Net Income

563 M 55.6 M 40 M 38.1 M 32.8 M 36.9 M 34.1 M 43.2 M 28.5 M 35.2 M 30.9 M - 29.3 M 39.8 M 34.5 M - 34.5 M 21.7 M 8.4 M - 30.8 M 39.2 M 35.3 M 37.1 M 42.6 M 44.4 M 61 M 42 M 42.8 M 40 M 35.7 M 37.1 M 41 M 37.8 M 38.4 M 37.8 M 39.1 M 38.2 M 44.2 M 41.2 M 33 M 44.6 M 32.7 M 54.4 M 33.6 M 31.2 M 29.7 M 27.5 M 25.2 M 25.3 M 23.5 M 27.8 M 42.7 M 19.9 M 15.7 M 41.1 M 14.4 M 16.9 M 18.3 M 18.1 M 18.8 M 25.1 M 19.1 M 17 M 17.3 M 19.2 M

Revenue

47.7 M 44.8 M 37.1 M 30.7 M 21.2 M 14.2 M 13.9 M 14 M 13.8 M 13.4 M 13.3 M - 80.1 M 77.9 M 82.4 M - 76.3 M 59.9 M 71.3 M - 73.8 M 74.3 M 6.14 M 81.3 M 6.48 M 6.26 M 6.55 M 82.2 M 6.44 M 5.52 M 5.15 M 74 M 3.23 M 3.09 M 3.49 M 71.1 M 3.15 M 4.1 M 3.09 M 65 M 3.67 M 3.31 M 3.16 M 58.6 M 2.51 M 2.52 M 2.12 M 45.7 M 1.75 M 1.75 M 1.76 M 32.8 M 1.94 M 1.97 M 1.97 M 25.9 M 1.88 M 1.85 M 1.7 M 21.5 M 1.69 M 1.63 M 1.6 M 19.5 M 19.7 M 19.2 M

Cost of Revenue

19.5 M 18.3 M 14.7 M 11.7 M 7.17 M 4.32 M 4.3 M 4.44 M 4.3 M 4.2 M 4.23 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

28.2 M 26.5 M 22.4 M 19 M 14 M 9.89 M 9.64 M 9.57 M 9.47 M 9.19 M 9.03 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - 42.8 M 40 M 35.7 M - 41 M 37.8 M 39.2 M - 39.6 M 38.3 M 34.1 M - 33.5 M 18.6 M 31.7 M - - - - - 25.5 M 25.6 M 23.9 M - 22.3 M 18.5 M 14.2 M - 13.3 M 15.9 M 17.2 M - 17.7 M 23.8 M 15.5 M - 15.4 M 15.2 M

Interest Expense

12.5 M 15.8 M 15 M 14.3 M 13.8 M 15 M 14.3 M -150 M 69.4 M 71.7 M 68.5 M - 15.1 M 14.2 M 14 M - 11.4 M 10.9 M 10.2 M - 12.7 M 12.8 M 13 M - 12.9 M 13.6 M 14.1 M - 14.7 M 13.7 M 13.5 M - 12.4 M 12.2 M 11.6 M - 11.7 M 11.7 M 11.7 M - 10.8 M 10.7 M 10.3 M - 9.77 M 9.29 M 8.41 M - 7 M 6.83 M 6.89 M - 3.29 M 1.6 M 1.12 M - 854 K 747 K 575 K - 1.78 M 1.59 M 477 K - - -

EBITDA

25.8 M 25.5 M 23.7 M 21.7 M 20.2 M 19.9 M 19.2 M 18.7 M 17.8 M 17.5 M 17.5 M - - - - - 17.5 M 17.8 M 18.3 M - 20 M 20.7 M 20.8 M - 20.8 M 20.8 M 20.4 M - 62.4 M 59 M 54.2 M - 59.1 M 55.6 M 56.5 M - 56.6 M 55.2 M 50.3 M - 48.7 M 33.3 M 45.4 M - 13.5 M 13 M - - 25.5 M 25.6 M 23.9 M - 22.3 M 18.5 M 14.2 M - 13.3 M 15.9 M 17.2 M - 17.7 M 23.8 M 15.5 M - 15.4 M 15.2 M

Operating Expenses

96.2 M 87.3 M 78 M 69.8 M 57.6 M 55.6 M 56 M 54.2 M 54.8 M 51.8 M 51.1 M - 52 M 49.7 M 49.6 M - 56.9 M 49.6 M 66.2 M - 62.4 M 40.7 M 44.2 M - 40.9 M 38.9 M 42.6 M - 38.9 M 38.1 M 40.4 M - 33.9 M 35.1 M 33.6 M - 31.8 M 31.5 M 32.2 M - 29.8 M 42.6 M 27.3 M - 25.3 M 24.6 M 25.6 M - 18.9 M 18.6 M 19.4 M - 8.69 M 8.7 M 12.9 M - 11.1 M 5.99 M 6.84 M - 6.12 M 6.15 M 6.45 M - 4.28 M 4.01 M

General and Administrative Expenses

8 M 8.82 M 7.85 M 7.6 M 6.31 M 6.12 M 6.83 M 5.42 M 4.81 M 4.87 M 5.64 M - 4.43 M 4.31 M 5.65 M - 4.74 M 5.05 M 8.1 M - 3.65 M 3.59 M 7.99 M - 2.78 M 3.03 M 4.31 M - 2.8 M 2.97 M 4.01 M - 2.79 M 2.76 M 4.17 M - 2.51 M 2.52 M 4.11 M - 2.17 M 2.12 M 2.93 M - 1.69 M 2.51 M 3.84 M - 2.16 M 1.85 M 2.94 M - 1.76 M 2.32 M 3.09 M - 1.64 M 1.59 M 2.79 M - 1.23 M 1.29 M 3.84 M - 1.26 M 1.33 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements National Health Investors NHI
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting National Health Investors plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Reit healthcare industry

Issuer Price % 24h Market Cap Country
Sabra Health Care REIT Sabra Health Care REIT
SBRA
$ 20.97 -1.67 % $ 5.06 B usaUSA
Ventas Ventas
VTR
$ 90.34 -0.01 % $ 41.1 B usaUSA
Welltower Welltower
WELL
$ 247.13 -0.21 % $ 164 B usaUSA
The GEO Group The GEO Group
GEO
$ 32.7 2.46 % $ 4.5 B usaUSA
LTC Properties LTC Properties
LTC
$ 43.94 -1.21 % $ 2.03 B usaUSA
Omega Healthcare Investors Omega Healthcare Investors
OHI
$ 48.11 -1.21 % $ 14 B usaUSA
Global Medical REIT Global Medical REIT
GMRE
- - $ 2.37 B usaUSA
Healthpeak Properties Healthpeak Properties
PEAK
- 2.09 % $ 9.35 B usaUSA